Institutional shares held 11.9 Million
24.1K calls
0 puts
Total value of holdings $30.3M
$61K calls
$0 puts
Market Cap $96.2M
37,892,300 Shares Out.
Institutional ownership 31.51%
# of Institutions 58


Latest Institutional Activity in AKYA

Top Purchases

Q3 2024
Paragon Associates & Paragon Associates Ii Joint Venture Shares Held: 790K ($2.01M)
Q3 2024
Gsa Capital Partners LLP Shares Held: 311K ($789K)
Q3 2024
Morgan Stanley Shares Held: 170K ($433K)
Q3 2024
Citadel Advisors LLC Shares Held: 51.8K ($132K)
Q3 2024
Goldman Sachs Group Inc Shares Held: 52.9K ($134K)

Top Sells

Q3 2024
Charles Schwab Investment Management Inc Shares Held: 63K ($160K)
Q3 2024
Bridgeway Capital Management, LLC Shares Held: 106K ($268K)
Q3 2024
Schonfeld Strategic Advisors LLC Shares Held: 271K ($689K)
Q3 2024
Jane Street Group, LLC Shares Held: 30.4K ($77.3K)
Q3 2024
Deutsche Bank Ag\ Shares Held: 10.9K ($27.6K)

About AKYA

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.


Insider Transactions at AKYA

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
1.23M Shares
From 8 Insiders
Grant, award, or other acquisition 836K shares
Exercise of conversion of derivative security 22.5K shares
Bona fide gift 370K shares
Sell / Disposition
443K Shares
From 7 Insiders
Payment of exercise price or tax liability 43.3K shares
Open market or private sale 30K shares
Bona fide gift 370K shares

Track Institutional and Insider Activities on AKYA

Follow Akoya Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKYA shares.

Notify only if

Insider Trading

Get notified when an Akoya Biosciences, Inc. insider buys or sells AKYA shares.

Notify only if

News

Receive news related to Akoya Biosciences, Inc.

Track Activities on AKYA